His main research concerns Internal medicine, Intensive care medicine, Surgery, Aspergillosis and Epidemiology. His work deals with themes such as Bacteremia and Fluconazole, which intersect with Internal medicine. His Intensive care medicine research includes elements of Cancer, Antibiotics, Incidence and Etiology.
Claudio Viscoli has included themes like Invasive fungal disease and Clinical trial in his Cancer study. His biological study spans a wide range of topics, including Amphotericin B and Antibacterial agent. His Aspergillosis research incorporates themes from Mycosis and Aspergillus.
Claudio Viscoli spends much of his time researching Internal medicine, Intensive care medicine, Immunology, Surgery and Aspergillosis. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology and Bacteremia. The Intensive care medicine study combines topics in areas such as Cancer, Antibiotics, Neutropenia and Clinical trial.
His research in Immunology intersects with topics in Acquired immunodeficiency syndrome and Virology. His research related to Mycosis, Retrospective cohort study and Regimen might be considered part of Surgery. His Aspergillosis study deals with Voriconazole intersecting with Fluconazole.
Claudio Viscoli mostly deals with Internal medicine, Intensive care medicine, Epidemiology, Incidence and Cohort. Many of his studies involve connections with topics such as Gastroenterology and Internal medicine. As a part of the same scientific study, Claudio Viscoli usually deals with the Gastroenterology, concentrating on Aspergillosis and frequently concerns with Mucormycosis and Voriconazole.
His work carried out in the field of Intensive care medicine brings together such families of science as Observational study, Antibiotics, Antibiotic resistance and Targeted therapy. His work in Antibiotic resistance addresses subjects such as Antimicrobial, which are connected to disciplines such as Surgery. His Incidence research is multidisciplinary, incorporating perspectives in Hepatitis C and Population study.
The scientist’s investigation covers issues in Internal medicine, Intensive care medicine, Antibiotic resistance, Antibiotics and Bacteremia. His research in Confidence interval, Incidence, Transplantation, Neutropenia and Septic shock are components of Internal medicine. His study in Septic shock is interdisciplinary in nature, drawing from both Epidemiology, Intensive care unit and Anesthesiology.
His Critically ill study in the realm of Intensive care medicine connects with subjects such as Special populations. The concepts of his Bacteremia study are interwoven with issues in Retrospective cohort study, Klebsiella pneumoniae, Combination therapy and Pneumonia. His Surgery research includes themes of Cirrhosis and Staphylococcus aureus.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens.
Clinical Infectious Diseases (2008)
ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.
O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino.
Clinical Microbiology and Infection (2012)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning.
Clinical Microbiology and Infection (2018)
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy
Mario Tumbarello;Pierluigi Viale;Claudio Viscoli;Enrico Maria Trecarichi.
Clinical Infectious Diseases (2012)
Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial
B J Kullberg;J D Sobel;M Ruhnke;P G Pappas.
The Lancet (2005)
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner.
Clinical Infectious Diseases (2008)
International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).
Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul.
Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study
Mario Tumbarello;Enrico Maria Trecarichi;Francesco Giuseppe De Rosa;Maddalena Giannella.
Journal of Antimicrobial Chemotherapy (2015)
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.
Diana Averbuch;Christina Orasch;Catherine Cordonnier;David M. Livermore.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: